Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Mazen Darwazah. Officer active across 1 company, notably Hikma Pharmaceuticals PLC. Cumulatively, 16 reports have been logged. History available since 30 April 2025. The latest transaction was disclosed on 19 December 2025 (Purchase). Regulator: RNS (LSE). All data is free.
Declarations 16 total
0
GB00B0LCW083⌘ RNS:9597628-1 Ideal exit: 26 Feb 2027 (T+270) 93,413 shares GB00B0LCW083⌘ RNS:d44dbdfb-743e-4c57-a372-497ad09925dd-1 Ideal exit: 26 Feb 2027 (T+270) 162,499 shares GB00B0LCW083⌘ RNS:8692df49-f37d-43c7-8ebe-66aeba9a2ed8-1 100,000 shares @ £14.986 14.6% of flow GB00B0LCW083⌘ RNS:02e0e3f6-5e31-417f-ad30-2a48a62cf093 Ideal exit: 15 Sept 2026 (T+270) 0
GB00B0LCW083⌘ RNS:44e56f15-4b95-4b75-bfc2-1e3ece1e9101-1 0
GB00B0LCW083⌘ RNS:339271ca-f805-4a7a-bc0f-077209d752f7-1 315,000 shares @ £16.07 57.1% of flow GB00B0LCW083⌘ RNS:5e5506bf-dd0d-490e-af93-009bdcb91748-0 Ideal exit: 3 Aug 2026 (T+270) 14,000 shares @ £16.03 2.6% of flow GB00B0LCW083⌘ RNS:5824423 Ideal exit: 13 Jun 2026 (T+270) 200,000 shares @ £17.56 40.3% of flow GB00B0LCW083⌘ RNS:5773971 Ideal exit: 4 May 2026 (T+270) 36,171 shares GB00B0LCW083⌘ RNS:5680033-2 Ideal exit: 24 Feb 2026 (T+270) 0
GB00B0LCW083⌘ RNS:5662058-1 0
GB00B0LCW083⌘ RNS:5636241-1 128,418 shares GB00B0LCW083⌘ RNS:5613092-2 14,844 shares GB00B0LCW083⌘ RNS:5560504-2 Ideal exit: 25 Nov 2025 (T+270) 131,789 shares GB00B0LCW083⌘ RNS:5139884-2 40,715 shares GB00B0LCW083⌘ RNS:5103062-2 Ideal exit: 7 Dec 2024 (T+270)